Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exagen (XGN) Shares Outstanding (Diluted Average) (2020 - 2025)

Exagen's Shares Outstanding (Diluted Average) history spans 6 years, with the latest figure at $21.6 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 18.43% year-over-year to $21.6 million; the TTM value through Dec 2025 reached $21.6 million, up 18.43%, while the annual FY2025 figure was $21.6 million, 18.43% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $21.6 million in Q4 2025 per XGN's latest filing, down from $22.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $22.9 million in Q3 2025 to a low of $12.9 million in Q1 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $17.8 million, with a median of $17.6 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): skyrocketed 34.02% in 2021, then grew 0.77% in 2022.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $16.0 million in 2021, then increased by 6.95% to $17.1 million in 2022, then grew by 3.5% to $17.7 million in 2023, then rose by 2.96% to $18.2 million in 2024, then grew by 18.43% to $21.6 million in 2025.
  • Per Business Quant, the three most recent readings for XGN's Shares Outstanding (Diluted Average) are $21.6 million (Q4 2025), $22.9 million (Q3 2025), and $19.8 million (Q2 2025).